Global Cord Blood Corp logo

CO

Global Cord Blood Corp

$2.4

Earnings Summary

Revenue
$297.21Mn
Net Profits
$104.72Mn
Net Profit Margins
35.23%
PE Ratio
4.1

Highlights

Revenue:

Global Cord Blood Corp’s revenue fell -1.69% since last year same period to $297.21Mn in the Q1 2022. On a quarterly growth basis, Global Cord Blood Corp has generated -6.3% fall in its revenue since last 3-months.

Net Profits:

Global Cord Blood Corp’s net profit fell -18.02% since last year same period to $104.72Mn in the Q1 2022. On a quarterly growth basis, Global Cord Blood Corp has generated -21.97% fall in its net profits since last 3-months.

Net Profit Margins:

Global Cord Blood Corp’s net profit margin fell -16.61% since last year same period to 35.23% in the Q1 2022. On a quarterly growth basis, Global Cord Blood Corp has generated -16.72% fall in its net profit margins since last 3-months.

PE Ratio:

Global Cord Blood Corp’s price-to-earnings ratio after this Q1 2022 earnings stands at 4.1.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Global Cord Blood Corp post its latest quarter earnings

EPS Estimate Current Year
0

Highlights

EPS Estimate Current Year:

Global Cord Blood Corp’s earning per share (EPS) estimates for the current year stand at 0.

Key Ratios

Key ratios of the Global Cord Blood Corp post its Q1 2022 earnings

Return on Assets (ROA)
0.05
Return on Equity (ROE)
0.11
Dividend Per Share (DPS)
0

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Global Cord Blood Corp’s return on assets (ROA) stands at 0.05.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Global Cord Blood Corp’s return on equity (ROE) stands at 0.11.

Dividend Per Share (DPS):

Global Cord Blood Corp declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2020-04-27
0
0.15
+Inf%

Company Information

Global Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and the only cord blood banking operator with multiple licenses. Global Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services.

Organisation
Global Cord Blood Corp
Employees
1.26K
Industry
Health Services